230
Views
19
CrossRef citations to date
0
Altmetric
Review

Improving adherence to gout therapy: an expert review

&
Pages 793-802 | Published online: 03 May 2018

References

  • RoddyEZhangWDohertyMThe changing epidemiology of goutNat Clin Pract Rheumatol20073844344917664951
  • SmithEHoyDCrossMThe global burden of gout: estimates from the Global Burden of Disease 2010 studyAnn Rheum Dis20147381470147624590182
  • KuoCFGraingeMJMallenCZhangWDohertyMRising burden of gout in the UK but continuing suboptimal management: a nationwide population studyAnn Rheum Dis201574466166724431399
  • WheltonAMacdonaldPAZhaoLHuntBGunawardhanaLRenal function in gout: long-term treatment effects of febuxostatJ Clin Rheumatol201117171321169856
  • KhannaPPNukiGBardinTTophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional surveyHealth Qual Life Outcomes20121011722999027
  • TriesteLPallaIFuscoFThe economic impact of gout: a systematic literature reviewClin Exp Rheumatol2012304 Suppl 73S145S14823072897
  • Perez-RuizFMartinez-IndartLCarmonaLHerrero-BeitesAMPijoanJIKrishnanETophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with goutAnn Rheum Dis201473117718223313809
  • VincentZLGambleGHouseMPredictors of mortality in people with recent-onset gout: a prospective observational studyJ Rheumatol201744336837327980010
  • DesideriGCastaldoGLombardiAIs it time to revise the normal range of serum uric acid levels?Eur Rev Med Pharmacol Sci20141891295130624867507
  • TauscheAKJansenTLSchroderHEBornsteinSRAringerMMüller-LadnerUGout–current diagnosis and treatmentDtsch Arztebl Int200910634–3554955519795010
  • KiltzUSmolenJBardinTTreat-to-target (T2T) recommendations for goutAnn Rheum Dis201676463263827658678
  • RichettePDohertyMPascualE2016 updated EULAR evidence-based recommendations for the management of goutAnn Rheum Dis2017761294227457514
  • BriesacherBAAndradeSEFouayziHChanKAComparison of drug adherence rates among patients with seven different medical conditionsPharmacotherapy200828443744318363527
  • WHOAdherence to long-term therapies. Evidence for action Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/Accessed April 16, 2018
  • HigueraLCarlinCSAndersonSAdherence to disease-modifying therapies for multiple sclerosisJ Manag Care Spec Pharm201622121394140127882830
  • MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
  • SpectorSLKinsmanRMawhinneyHCompliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trialsJ Allergy Clin Immunol1986771 Pt 165703511127
  • TanCTengGGChongKJUtility of the Morisky Medication Adherence Scale in gout: a prospective studyPatient Prefer Adherence2016102449245727980395
  • de AchavalSSuarez-AlmazorMEImproving treatment adherence in patients with rheumatologic diseaseJ Musculoskelet Med20102710169147624078770
  • McGowanBBennettKSilkeCWhelanBAdherence and persistence to urate-lowering therapies in the Irish settingClin Rheumatol201635371572125409858
  • VitolinsMZRandCSRappSRRibislPMSevickMAMeasuring adherence to behavioral and medical interventionsControl Clin Trials2000215 Suppl188S194S11018574
  • WuEQPatelPAYuAPDisease-related and all-cause health care costs of elderly patients with goutJ Manag Care Pharm200814216417518331118
  • FischerACloutierMGoodfieldJBorrelliRMarvinDDziarmagaAThe direct economic burden of gout in an elderly Canadian populationRheumatol201744195101
  • AbhishekAJenkinsWLa-CretteJFernandesGDohertyMLong-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept studyRheumatology (Oxford)201756452953328082620
  • HillJBirdHJohnsonSEffect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomized controlled trialAnn Rheum Dis200160986987511502614
  • NICEMedicines adherence: involving patients in decisions about prescribed medicines and supporting adherenceClinical guideline CG76 Available from: https://www.nice.org.uk/guidance/cg76/resources/medicines-adherence-involving-patients-in-decisions-about-prescribed-medicines-and-supporting-adherence-pdf-975631782085Accessed April 18, 2018
  • Garcia-PerezLEAlvarezMDillaTGil-GuillénVOrozco-BeltránDAdherence to therapies in patients with type 2 diabetesDiabetes Ther20134217519423990497
  • Dunbar-JacobJErlenJASchlenkEARyanCMSereikaSMDoswellWMAdherence in chronic diseaseAnnu Rev Nurs Res200018489010918932
  • HugtenburgJGTimmersLEldersPJVervloetMvan DijkLDefinitions, variants, and causes of nonadherence with medication: a challenge for tailored interventionsPatient Prefer Adherence2013767568223874088
  • NilssonJLAnderssonKBergkvistABjörkmanIBrismarAMoenJRefill adherence to repeat prescriptions of cancer drugs to ambulatory patientsEur J Cancer Care (Engl)200615323523716882118
  • VrijensBVinczeGKristantoPUrquhartJBurnierMAdherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing historiesBMJ200833676531114111718480115
  • TomaszewskiMWhiteCPatelPHigh rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysisHeart20141001185586124694797
  • NHLBIPrevention, Detection, Evaluation, and Treatment of High Blood Pressure Available from: https://www.nhlbi.nih.gov/files/docs/guidelines/jnc7full.pdfAccessed April 18, 2018
  • CramerJAA systematic review of adherence with medications for diabetesDiabetes Care20042751218122415111553
  • De VeraMAMarcotteGRaiSGaloJSBholeVMedication adherence in gout: a systematic reviewArthritis Care Res (Hoboken)201466101551155924692321
  • HarroldLRAndradeSEBriesacherBAAdherence with urate-lowering therapies for the treatment of goutArthritis Res Ther2009112R4619327147
  • Zandman-GoddardGAmitalHShamrayevskyNRazRShalevVChodickGRates of adherence and persistence with allopurinol therapy among gout patients in IsraelRheumatology (Oxford)20135261126113123392592
  • MantarroSCapogrosso-SansoneATuccoriMAllopurinol adherence among patients with gout: an Italian general practice database studyInt J Clin Pract201569775776525683693
  • CorbettEJPentonyPMcGillNWAchieving serum urate targets in gout: an audit in a gout-oriented rheumatology practiceInt J Rheum Dis201720789489728205336
  • DehlinMEkstromEHPetzoldMStrömbergUTelgGJacobssonLTFactors associated with initiation and persistence of urate-lowering therapyArthritis Res Ther2017191628095891
  • RichettePFlipoRNPatrikosDKCharacteristics and management of gout patients in Europe: data from a large cohort of patientsEur Rev Med Pharmacol Sci201519463063925753881
  • ChiaFLPoorly controlled gout: who is doing poorly?Singapore Med J201657841241427549096
  • Nasser-GhodsiNHarroldLROvercoming adherence issues and other barriers to optimal care in goutCurr Opin Rheumatol201527213413825633242
  • HarroldLRMazorKMVeltenSOckeneISYoodRAPatients and providers view gout differently: a qualitative studyChronic Illn20106426327120675361
  • SinghJAFacilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative studyArthritis Res Ther2014162R8224678765
  • SpencerKCarrADohertyMPatient and provider barriers to effective management of gout in general practice: a qualitative studyAnn Rheum Dis20127191490149522440822
  • SolomonDHAvornJLevinRBrookhartMAUric acid lowering therapy: prescribing patterns in a large cohort of older adultsAnn Rheum Dis200867560961317728328
  • KuoCFGraingeMJMallenCZhangWDohertyMEligibility for and prescription of urate-lowering treatment in patients with incident gout in EnglandJAMA2014312242684268625536262
  • VaccherSKannangaraDRBaysariMTBarriers to care in gout: from prescriber to patientJ Rheumatol201643114414926568590
  • AnnemansLSpaepenEGaskinMGout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005Ann Rheum Dis200867796096617981913
  • ReesFHuiMDohertyMOptimizing current treatment of goutNat Rev Rheumatol201410527128324614592
  • MikulsTRMacLeanCHOlivieriJQuality of care indicators for gout managementArthritis Rheum200450393794315022337
  • MikulsTRFarrarJTBilkerWBFernandesSSaagKGSuboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)Rheumatology (Oxford)20054481038104215870145
  • SpaetgensBPustjensTScheepersLEJMJanssensHJEMvan der LindenSBoonenAKnowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practiceClin Rheumatol20163582053206126898982
  • GoldfienRDNgMSYipGEffectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot studyBMJ Open201441e003627
  • CoburnBWCheethamTCRashidNRationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) StudyContemp Clin Trials20165010611527449546
  • ReesFJenkinsWDohertyMPatients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational studyAnn Rheum Dis201372682683022679303
  • RobinsonPCSchumacherHRJrA qualitative and quantitative analysis of the characteristics of gout patient education resourcesClin Rheumatol201332677177823322247
  • FieldsTRRifaatAYeeAMPilot study of a multidisciplinary gout patient education and monitoring programSemin Arthritis Rheum201746560160827931979
  • FernonANguyenABaysariMDayRA User-centred approach to designing an eTool for gout managementStud Health Technol Inform2016227283327440285
  • NguyenADBaysariMTKannangaraDRMobile applications to enhance self-management of goutInt J Med Inform201694677427573313
  • AungTMyungGFitzGeraldJDTreatment approaches and adherence to urate-lowering therapy for patients with goutPatient Prefer Adherence20171179580028458524